System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Farrakh Ali Abbas is an expert in Cardiology at University of Sargodha (Pakistan). Farrakh Ali Abbas has authored 8 publications, the most recent in 2025. SLR score: 23 (community average: 125). How the SLR is computed.

LeadR Profile

Farrakh Ali Abbas University of Sargodha Pakistan
23 ScienceLeadR Reputation 23

Unlock

Register Login
Network Map

Cardiology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2023 - 2025
Source: PubMed

University of Sargodha

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 8

Citations

Citations: 94 1st author: 2 Last author: 2 Unique author: 0

Main journals

Cardiovasc Toxicol 1
Health Sci Rep 1
Health Technol (Berl) 1
NUST Journal of Natural Sciences 1
Pharm World Sci 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Impact of Gene-Smoking Interaction on Risk of Atherosclerosis: Molecular Study of Prothrombin (F2) Gene rs1799963 G/A Polymorphism in Atherosclerotic Patients.
PMID 40261540 — genes, alleles, atherosclerosis, smoking, prothrombin		Cardiovasc Toxicol20250
Lumpy skin disease in Pakistan: unraveling the outbreak and charting future horizons
OpenAlex W4410285260 — skin, vaccines, skin diseases, vaccination, lumpy skin disease		NUST Journal of Natural Sciences20250
Alarming rise in HIV cases in Pakistan: Challenges and future recommendations at hand.
PMID 37520460 — hiv, viruses, sex, virus diseases		Health Sci Rep202341
Phytochemical, biological, and in-silico analysis of Colutea armata Hemsl. & Lace: A possible source of bioactive natural compounds
OpenAlex W4376155626 — phytochemicals		S Afr J Bot20237
Successful treatment of chronic hepatitis C virus infection with peginterferon alpha-2a and ribavirin in patients with sickle cell disease.
PMID 19417977 — hepatitis c, chronic, cells, hepatitis c, anemia, sickle cell, ribavirin, hepatitis, chronic, viruses, therapeutics, infections, hepatitis, virus diseases		Saudi Med J200915

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS